Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-23

Clinical Trial Update: Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of calcitriol on neurological symptoms in Friedreich ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitriol (calcitriol)

Snippet

Sponsor: Berta Alemany | Conditions: Friedreich Ataxia | Phase 4 | Status: COMPLETED